Trial intelligence / Profile preview

Milrinone for low central venous pressure during lumbar spine surgery

ChiCTR1900022610Phase 4Not yet recruiting

Sponsor
Huadong Hospital, Fudan University
Start
May 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of milrinone in intraoperative bleeding (2 arms), sponsored by Huadong Hospital, Fudan University. Primary endpoints: Intraoperative blood loss, Autologous blood transfusion and 1 more. Planned start May 2019; status: not yet recruiting.

02

Drugs

milrinone
03

Conditions

intraoperative bleeding

Beyond the preview

Go deeper on ChiCTR1900022610.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1900022610.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call